Adult Vaccines for Respiratory Syncytial Virus

ABOUT THIS EPISODE

Originally aired: October 5, 2023

This podcast highlights the impact of respiratory syncytial virus (RSV) on older adults. Experts discuss RSV’s pathophysiology, risk factors, potential complications, and the vital role of new vaccines in protecting the aging population.

Supported by an independent medical educational grant from GSK

Moderator
Kelly Pennington, MD

Panelist
Ryan C. Maves, MD, FCCP